It was suggested that elevated MALAT1 expression predicted a poor outcome for OS in 12 types of cancers (pooled HR = 1.91, 95 % CI 1.49–2.34) with no heterogeneity (I2 = 0.0 %, P = 0.728) (Fig. 2). This evidence concerns the gene MALAT1 and cancer.